Applied Clinical Trials Digital Edition - April/May 2015

Article

Applied Clinical Trials

Applied Clinical TrialsApplied Clinical Trials-04-01-2015
Volume 35
Issue 3

Trial Design: Breaking Blood Cancer Barriers Adaptive Solutions in Oncology Clinical Technology: Tumor Imaging Ascension Sites: Enrollment Forecast Data Also in this issue: Innovation Initiative Debate in Europe R&D Investment: Public vs. Private The Psychology of Cancer

External Link - 2015-04ACT.pdf

Download Issue PDF
Articles in this issue
i1-1.gif
Public Opinion Matters—And Merits Attention
i1-6.jpg
Giving Pharma Credit for Medical Innovation
i2.gif
Overcoming Challenges in Hematological Cancer Trials
i1-8.jpg
Improving Oncology Trials Through Adaptive Designs
The Evolution of Imaging Techniques in Clinical Trials
The Evolution of Imaging Techniques in Clinical Trials
i1-11.jpg
The Psychology of Cancer: Suicidal Ideation in Clinical Trials
i12.gif
Forecast Enrollment Rate in Clinical Trials
Adaptive Trial Designs Gaining Momentum
Adaptive Trial Designs Gaining Momentum
Congress, White House Seek to Spur Biomedical Innovation
EFGCP Issues Roadmap on Medical Devices
FDA, Sponsors Look to Expand Patient Input to Clinical Trials
Report Spotlights Progress, Challenges in Oncology Practice
i1.gif
FDA’s Expedited Review Process: The Need for Speed
i21428963648113.jpg
Planning for Success in Late Phase Global Oncology Trials
Applied Clinical Trials Digital Edition - April/May 2015
Recent Videos
Related Content
© FlowStudio - © FlowStudio - stock.adobe.com.

Using Data Patterns to Proactively Improve Study Quality

Sylviane de Viron;Steve Young
December 20th 2024
Article

Recent analysis showed 81% of clinical trial sites using RBQM statistical data monitoring experienced an improvement in quality.

Driving Diversity with the Integrated Research Model

Driving Diversity with the Integrated Research Model

Andy Studna, Editor
October 16th 2024
Podcast

Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.

© Minerva Studio - © Minerva Studio - stock.adobe.com

Palatin Announces Positive Results From Phase IIb BREAKOUT Study

Andy Studna, Editor
December 19th 2024
Article

In patients with type 2 diabetic nephropathy, bremelanotide demonstrated efficacy in reducing urine protein to creatinine ratio and improving or stabilizing estimated glomerular filtration rate.

AI in Clinical Trials: A Long, But Promising Road Ahead

AI in Clinical Trials: A Long, But Promising Road Ahead

Miranda Schmalfuhs
May 29th 2024
Podcast

Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.

© Sebastian Kaulitzki - © Sebastian Kaulitzki - stock.adobe.com..

Teva and Sanofi Share Positive Results from Phase II Study in Ulcerative Colitis and Crohn’s Disease

Andy Studna, Editor
December 18th 2024
Article

Duvakitug, a monoclonal antibody, demonstrated clinical remission and endoscopic response in the study, meeting its primary endpoints.

Credit: Mopic | stock.adobe.com

Imlunestrant Both as Monotherapy and in Combination Shows Promising Survival Benefits for ER-Positive, HER2-Negative Advanced Breast Cancer

Davy James
December 18th 2024
Article

Results from the EMBER-3 trial show imlunestrant, both as monotherapy and in combination with Verzenio (abemaciclib), significantly improved progression-free survival in ESR1-mutated ER-positive, HER2-negative advanced breast cancer.

© 2024 MJH Life Sciences

All rights reserved.